• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission.

作者信息

Bozzalla Cassione Emanuele, Mansoubi Mehrad, Mazzucchelli Iolanda, Luvaro Terenzj, De Stefano Ludovico, Xoxi Blerina, Grignaschi Silvia, Bugatti Serena, Montecucco Carlomaurizio, Manzo Antonio

机构信息

Rheumatology and Translational Immunology Research Laboratories (LaRIT), Department of Internal Medicine and Therapeutics, Università Di Pavia, Viale Camillo Golgi 19, Pavia, 27100, Italy.

Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

出版信息

Clin Rheumatol. 2022 Aug;41(8):2605-2607. doi: 10.1007/s10067-022-06250-8. Epub 2022 Jun 22.

DOI:10.1007/s10067-022-06250-8
PMID:35729370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9213093/
Abstract
摘要

相似文献

1
No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission.无证据表明重复接种BNT162b2疫苗对处于药物缓解期的类风湿关节炎内环境稳定有短期影响。
Clin Rheumatol. 2022 Aug;41(8):2605-2607. doi: 10.1007/s10067-022-06250-8. Epub 2022 Jun 22.
2
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis.类风湿关节炎患者接种SARS-CoV-2 mRNA疫苗6个月后B细胞和T细胞免疫反应的动力学
Front Immunol. 2022 Feb 28;13:846753. doi: 10.3389/fimmu.2022.846753. eCollection 2022.
3
Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab.接受利妥昔单抗治疗的类风湿关节炎患者接种新型冠状病毒疫苗后特异性T细胞反应的存在情况。
Immunol Res. 2021 Aug;69(4):309-311. doi: 10.1007/s12026-021-09212-5. Epub 2021 Jul 29.
4
Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses.SARS-CoV-2 疫苗在接受 DMARDs 治疗的类风湿关节炎（RA）患者中的有效性：通过抗体和 T 细胞应答来确定。
RMD Open. 2022 Mar;8(1). doi: 10.1136/rmdopen-2021-002050.
5
[Homeostasis and Disorder of Musculoskeletal System.Progress in the treatment of rheumatoid arthritis.].[骨骼肌肉系统的稳态与紊乱。类风湿关节炎的治疗进展。]
Clin Calcium. 2018;28(3):395-401.
6
Clinical characteristics associated with drug-free sustained remission in patients with rheumatoid arthritis: Data from Korean Intensive Management of Early Rheumatoid Arthritis (KIMERA).与类风湿关节炎患者药物免费持续缓解相关的临床特征：来自韩国早期类风湿关节炎强化管理（KIMERA）的数据。
Semin Arthritis Rheum. 2020 Dec;50(6):1414-1420. doi: 10.1016/j.semarthrit.2020.02.014. Epub 2020 Feb 29.
7
Influenza vaccination status in rheumatoid arthritis and spondyloarthritis patients receiving biologic DMARDs.接受生物性改善病情抗风湿药治疗的类风湿关节炎和脊柱关节炎患者的流感疫苗接种状况
Joint Bone Spine. 2016 Mar;83(2):237-8. doi: 10.1016/j.jbspin.2015.02.016. Epub 2015 Jul 17.
8
A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.抗风湿药物和疫苗免疫原性在类风湿关节炎中的系统评价和荟萃分析。
J Rheumatol. 2018 Jun;45(6):733-744. doi: 10.3899/jrheum.170710. Epub 2018 Mar 15.
9
Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms.类风湿关节炎的疾病缓解药物停药后持续缓解：随着疾病症状的消退，越来越有可能实现这一目标。
Ann Rheum Dis. 2016 May;75(5):867-73. doi: 10.1136/annrheumdis-2014-207080. Epub 2015 May 13.
10
Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.类风湿关节炎中持续停用改善病情抗风湿药缓解的患病率及预测因素：来自两个大型早期关节炎队列的结果
Arthritis Rheum. 2009 Aug;60(8):2262-71. doi: 10.1002/art.24661.

本文引用的文献

1
Insights Into the Concept of Rheumatoid Arthritis Flare.类风湿关节炎发作概念的见解。
Front Med (Lausanne). 2022 Mar 17;9:852220. doi: 10.3389/fmed.2022.852220. eCollection 2022.
2
Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong.香港类风湿关节炎患者接种两剂 COVID-19 疫苗与关节炎发作的相关性。
Ann Rheum Dis. 2022 Apr;81(4):564-568. doi: 10.1136/annrheumdis-2021-221571. Epub 2021 Oct 22.
3
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.27名受试者在接种mRNA/DNA新冠病毒疫苗后出现免疫介导疾病发作或新发疾病
Vaccines (Basel). 2021 Apr 29;9(5):435. doi: 10.3390/vaccines9050435.
4
First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染后抗环瓜氨酸肽抗体（ACPA）阳性类风湿性关节炎的首次发作
Lancet Rheumatol. 2021 Jan;3(1):e6-e8. doi: 10.1016/S2665-9913(20)30396-9. Epub 2020 Nov 23.
5
Six-month flare risk after discontinuing long-term methotrexate treatment in patients having rheumatoid arthritis with low disease activity.类风湿关节炎患者低疾病活动度下停止长期甲氨蝶呤治疗后 6 个月的 flares 风险。
Int J Rheum Dis. 2020 Aug;23(8):1076-1081. doi: 10.1111/1756-185X.13888. Epub 2020 Jul 6.
6
Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study.基于 DAS28 的几种拟议类风湿关节炎发作标准的构建和标准效度：一项 OMERACT 队列验证研究。
Ann Rheum Dis. 2013 Nov;72(11):1800-5. doi: 10.1136/annrheumdis-2012-202281. Epub 2012 Nov 23.
7
Every-other-week methotrexate in patients with rheumatoid arthritis. A double-blind, placebo-controlled prospective study.类风湿关节炎患者每两周一次甲氨蝶呤治疗。一项双盲、安慰剂对照的前瞻性研究。
Arthritis Rheum. 1995 May;38(5):601-7. doi: 10.1002/art.1780380504.